https://thelifesciencefeed.com/rheumatology/arthritis-rheumatoid/research/ra-patients-face-elevated-fracture-risk-eular-2026-highlights The Life Science Feed en 2026-06-04T00:00:00Z RA Patients Face Elevated Fracture Risk: EULAR 2026 Highlights https://thelifesciencefeed.com/general-practice/preventive-health-services/news/federal-research-supports-lower-drinking-limits-for-health The Life Science Feed en 2026-06-11T16:20:59Z Federal Research Supports Lower Drinking Limits for Health https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-2/news/orforglipron-phase-3-trials-show-efficacy-in-t2d-management The Life Science Feed en 2026-06-11T16:20:35Z Orforglipron Phase 3 Trials Show Efficacy in T2D Management https://thelifesciencefeed.com/oncology/brain-neoplasms/insights/ctdna-predicts-relapse-in-early-cancer-but-clinical-action-remains-unclear The Life Science Feed en 2026-06-11T16:20:07Z ctDNA Predicts Relapse in Early Cancer, but Clinical Action Remains Unclear https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-2/research/acupuncture-reduces-insulin-needs-in-type-2-diabetes The Life Science Feed en 2026-06-11T16:19:43Z Acupuncture Reduces Insulin Needs in Type 2 Diabetes https://thelifesciencefeed.com/infectious-diseases/covid19/news/c-difficile-hospital-deaths-rose-during-covid-19-pandemic The Life Science Feed en 2026-06-11T16:19:13Z C. difficile Hospital Deaths Rose During COVID-19 Pandemic https://thelifesciencefeed.com/obstetrics-and-gyn/pregnancy-complications/guidelines/acog-simplifies-maternal-immunisation-schedule-for-gps The Life Science Feed en 2026-06-11T16:18:51Z ACOG Simplifies Maternal Immunisation Schedule for GPs https://thelifesciencefeed.com/nephrology/chronic-kidney-disease/research/waist-size-muscle-mass-predict-ckd-prognosis-mortality-risk The Life Science Feed en 2026-06-11T16:18:04Z Waist Size, Muscle Mass Predict CKD Prognosis, Mortality Risk https://thelifesciencefeed.com/dermatology/plaque-psoriasis/research/psoriasis-chronic-intense-pain-multiple-sites The Life Science Feed en 2026-06-11T16:17:33Z Psoriasis Patients Report Chronic Intense Pain, Multiple Pain Sites https://thelifesciencefeed.com/genetics/gene-therapy/innovation/exosomes-emerge-as-cell-free-option-in-regenerative-medicine The Life Science Feed en 2026-06-11T16:17:12Z Exosomes Emerge as Cell-Free Option in Regenerative Medicine https://thelifesciencefeed.com/pain-and-palliative-care/neuralgia/research/dexamethasone-offers-no-benefit-in-headache-after-occipital-nerve-block The Life Science Feed en 2026-06-11T16:16:49Z Dexamethasone Offers No Benefit in Headache After Occipital Nerve Block https://thelifesciencefeed.com/healthcare-sys-and-biz/health-policy/news/patient-debt-complicates-doctor-patient-relationships-care-decisions The Life Science Feed en 2026-06-11T16:16:19Z Patient Debt Complicates Doctor-Patient Relationships, Care Decisions https://thelifesciencefeed.com/haematology/lymphoma/research/allogeneic-cell-therapy-ebv-ptld-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z Allogeneic Cell Therapy for EBV+ PTLD: EHA 2026 Insights https://thelifesciencefeed.com/haematology/leukemia/innovation/novel-therapies-improve-outcomes-post-cbtki-cll-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z Novel Therapies Improve Outcomes Post-cBTKi in CLL at EHA 2026 https://thelifesciencefeed.com/haematology/lymphoma/research/bispecific-antibodies-relapsed-follicular-lymphoma The Life Science Feed en 2026-06-11T00:00:00Z Bispecific Antibodies Positioned in Relapsed Follicular Lymphoma https://thelifesciencefeed.com/haematology/leukemia/research/cml-survivorship-beyond-survival-to-quality-of-life The Life Science Feed en 2026-06-11T00:00:00Z CML Survivorship: Beyond Survival to Quality of Life https://thelifesciencefeed.com/immunology/immune-thrombocytopenia/research/immune-drivers-autoimmune-cytopenias-patient-care The Life Science Feed en 2026-06-11T00:00:00Z Immune Drivers in Autoimmune Cytopenias Inform Patient Care https://thelifesciencefeed.com/haematology/lymphoma/news/car-t-therapy-sustained-efficacy-relapsed-refractory-lymphoma-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z CAR T Therapy Shows Sustained Efficacy in Relapsed/Refractory Lymphoma https://thelifesciencefeed.com/haematology/lymphoma/insights/dlbcl-treatment-emerging-targeted-therapies-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z DLBCL Treatment: Emerging Targeted Therapies at EHA 2026 https://thelifesciencefeed.com/haematology/immune-thrombocytopenia/research/caplacizumab-improves-ittp-outcomes-real-world The Life Science Feed en 2026-06-11T00:00:00Z Caplacizumab Improves iTTP Outcomes in Real-World Settings https://thelifesciencefeed.com/haematology/leukemia/research/aml-fitness-not-age-predicts-ic-eligibility-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z AML: Fitness, Not Age, Predicts IC Eligibility at EHA 2026 https://thelifesciencefeed.com/haematology/multiple-myeloma/research/bcma-directed-therapies-relapsed-refractory-multiple-myeloma-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z BCMA-Directed Therapies Show Efficacy in Relapsed/Refractory Multiple Myeloma https://thelifesciencefeed.com/haematology/lymphoma/research/car-t-dlbcl-patient-outcomes-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z CAR T in DLBCL: Optimising Patient Outcomes at EHA 2026 https://thelifesciencefeed.com/haematology/multiple-myeloma/research/novel-approaches-r-r-mm-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z Novel Approaches in R/R MM: Expert Perspectives from EHA 2026 https://thelifesciencefeed.com/haematology/myeloproliferative-disorders/research/iron-status-erythrocytosis-symptoms-polycythemia-vera-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z Iron Status Clarifies Erythrocytosis, Symptoms in Polycythemia Vera https://thelifesciencefeed.com/haematology/multiple-myeloma/research/cd38-mab-quad-therapy-subcutaneous-dosing-reduces-burden The Life Science Feed en 2026-06-11T00:00:00Z CD38 mAb Quad Therapy: Subcutaneous Dosing Reduces Burden https://thelifesciencefeed.com/haematology/lymphoma/research/dlbcl-treatment-sequencing-eha-2026-current-therapies The Life Science Feed en 2026-06-11T00:00:00Z DLBCL Treatment Sequencing: EHA 2026 Explores Current Therapies https://thelifesciencefeed.com/haematology/sickle-cell-disease/research/real-world-data-confirms-proximal-complement-inhibition-in-pnh The Life Science Feed en 2026-06-11T00:00:00Z Real-World Data Confirms Proximal Complement Inhibition in PNH https://thelifesciencefeed.com/haematology/leukemia/case/cll-first-line-therapy-case-based-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z CLL First-Line Therapy: Case-Based Insights from EHA 2026 https://thelifesciencefeed.com/haematology/multiple-myeloma/insights/multiple-myeloma-aligning-innovation-clinical-practice-eha-2026 The Life Science Feed en 2026-06-11T00:00:00Z Multiple Myeloma: Aligning Innovation with Clinical Practice at EHA 2026 https://thelifesciencefeed.com/haematology/immune-thrombocytopenia/case/rare-conditions-eha-2026-highlights-diagnostic-challenges The Life Science Feed en 2026-06-11T00:00:00Z Rare Conditions: EHA 2026 Highlights Diagnostic Challenges https://thelifesciencefeed.com/haematology/sickle-cell-disease/research/inflammation-drives-sickle-cell-disease-pathophysiology The Life Science Feed en 2026-06-10T10:12:41Z Inflammation Drives Sickle Cell Disease Pathophysiology https://thelifesciencefeed.com/haematology/myeloproliferative-disorders/research/avapritinib-improves-outcomes-nonadvanced-advanced-systemic-mastocytosis The Life Science Feed en 2026-06-10T10:08:10Z Avapritinib Improves Outcomes in Nonadvanced and Advanced Systemic Mastocytosis https://thelifesciencefeed.com/haematology/leukemia/research/flt3-inhibitors-aml-outcomes-transplant The Life Science Feed en 2026-06-10T10:07:46Z FLT3 Inhibitors Improve AML Outcomes Pre- and Post-Transplant https://thelifesciencefeed.com/haematology/leukemia/research/idh1m-aml-ivosidenib-azacitidine-improves-os The Life Science Feed en 2026-06-10T10:07:25Z IDH1m AML: Ivosidenib Plus Azacitidine Improves OS by 12.5 Months https://thelifesciencefeed.com/haematology/lymphoma/innovation/ai-hematology-eha-2026-practical-ethical-integration The Life Science Feed en 2026-06-10T10:07:07Z AI in Hematology: EHA 2026 Focuses on Practical, Ethical Integration https://thelifesciencefeed.com/haematology/multiple-myeloma/practice/bcma-bispecifics-community-myeloma-care-eha-2026 The Life Science Feed en 2026-06-10T10:06:46Z BCMA Bispecifics Transition to Community Myeloma Care: EHA 2026 https://thelifesciencefeed.com/haematology/myelodysplastic-syndromes/research/aml-rethinking-intensive-therapy-myelodysplasia-therapy-related The Life Science Feed en 2026-06-10T10:06:26Z AML: Rethinking Intensive Therapy for Myelodysplasia-Related & Therapy-Related Subtypes https://thelifesciencefeed.com/haematology/lymphoma/research/bispecific-antibodies-fl-eha-2026-advancing-outcomes The Life Science Feed en 2026-06-10T10:05:49Z Bispecific Antibodies in FL: EHA 2026 Explores Advancing Outcomes https://thelifesciencefeed.com/haematology/multiple-myeloma/research/mrd-status-guides-first-line-treatment-duration-haematologic-malignancies The Life Science Feed en 2026-06-10T10:05:25Z MRD Status Guides First-Line Treatment Duration in Haematologic Malignancies https://thelifesciencefeed.com/haematology/leukemia/case/aml-treatment-strategies-optimising-outcomes The Life Science Feed en 2026-06-10T10:05:05Z AML Treatment Strategies: Optimising Outcomes in a Complex Disease https://thelifesciencefeed.com/haematology/multiple-myeloma/news/bispecific-antibodies-relapsed-refractory-haematological-malignancies The Life Science Feed en 2026-06-10T10:04:41Z Bispecific Antibodies Show Promise in Relapsed/Refractory Haematological Malignancies https://thelifesciencefeed.com/haematology/leukemia/insights/cll-eha-2026-unmet-needs-treatment-selection The Life Science Feed en 2026-06-10T10:04:23Z CLL: EHA 2026 to Address Unmet Needs in Treatment Selection https://thelifesciencefeed.com/haematology/sickle-cell-disease/insights/optimising-transplant-haemoglobinopathies-eha-2026-perspectives The Life Science Feed en 2026-06-10T10:04:05Z Optimising Transplant in Haemoglobinopathies: EHA 2026 Perspectives https://thelifesciencefeed.com/haematology/myeloproliferative-disorders/news/jak-inhibitor-combinations-myelofibrosis-eha-2026 The Life Science Feed en 2026-06-10T10:03:45Z JAK Inhibitor Combinations Show Efficacy in Myelofibrosis at EHA 2026 https://thelifesciencefeed.com/haematology/lymphoma/insights/dlbcl-relapse-eha-2026-addresses-gaps-in-treatment-strategy The Life Science Feed en 2026-06-10T10:03:27Z DLBCL Relapse: EHA 2026 Addresses Gaps in Treatment Strategy https://thelifesciencefeed.com/haematology/multiple-myeloma/news/ndmm-treatment-advances-quadruplet-regimens-show-efficacy The Life Science Feed en 2026-06-10T00:00:00Z NDMM Treatment Advances: Quadruplet Regimens Show Efficacy